Trainline Raises FullYear Guidance for Second Time in FY2025 BioMarin Pharmaceutical Inc BMRN Q1 2026 Earnings EPS Miss Pressures Valuation Yet Stock Edges Higher Credit Suisses Mishra Sees Scope for Meaningful Rate Cuts Potential Market PickUp from December Osim Founder Ron Sim Drops Legal Claims Against Trek 2000 After Stake Sale at Premium Oil Prices Decline as Trump Signals Potential Iran Deal Employment Scams on the Rise Text Messages Fuel Surge in Fraud Cases Borosil Glass Works Shares Surge Over 200 in a Year on Strong Revenue and EBITDA Growth Bath Body Works Surpasses Sales Expectations Shares Jump 97 Traders Skeptical of Irans Strait of Hormuz Reopening Timeline Plus500 Reports 11 Quarterly Revenue Rise Says FullYear Outlook on Track SEBI Relaxes Nomination Rules for Demat Accounts Mutual Funds from September 2026